Sidley is representing Stryker (NYSE: SYK), a global leader in medical technologies, in its approximately US$4.9 billion acquisition of Inari Medical, Inc. (NASDAQ: NARI). On January 6, 2025, Stryker announced that it had entered into a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. Inari Medical is a medical manufacturer of peripheral vascular devices. The transaction will give Stryker entry into this high growth segment and expand its portfolio to help provide life-saving solutions to peripheral vascular patients.
The Sidley team is being led by Seth Katz, Scott R. Williams, and Sally Wagner Partin (M&A and Private Equity), and includes Leigh Rorick and Jeff Wysong (M&A and Private Equity); Kayla M. West (Capital Markets); Christian E. Pilhofer and Alexandra M. Peterson (Employee Benefits and Executive Compensation); Vadim Brusser and Patrick J. Harrison (Antitrust and Competition); Jaime Jones, Donielle McCutcheon, and Catherine Stewart (Healthcare); E. Kyle Barnett (Technology and Life Sciences Transactions); Stephanie P. Koh (IP Litigation); Yolanda C. Garcia (Securities and Shareholder Litigation); Mason Parham (Commercial Litigation and Disputes); and Rebecca Stuart (Employment).
